Showing results (231-240 of 442) with videos related to

Sort By:
Pageof 45
Acta Obstetricia Et Gynecologica Scandinavica|May 26, 2026
Pre-eclampsia risk-stratified planned birth at term: A survey of women's perspectives on acceptability and risk communicationJames Goadsby, Angel Leung, Sergio A Silverio, et al.
Hypertension in Pregnancy|September 8, 2010
Chlamydia pneumoniae infection in preeclampsiaFang Xie, Yuxiang Hu, Laura A Magee, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 26, 2026
Healthcare professionals' perceptions of the acceptability of the PREVENT-PE trial: A mixed-methods survey and interview studyAngel Leung, James Goadsby, Kayleigh S Sheen, et al.
Nutrients|January 28, 2026
Prevalence of Clinical and Pre-Clinical Obesity at Six Months Postpartum Following Gestational Diabetes MellitusCristina Gómez Fernández, Laura A Magee, Marietta Charakida, et al.
Journal of Nephrology|March 29, 2022
Comparison of catheters or new arteriovenous fistulas for commencement of haemodialysis in pregnant women with chronic kidney disease: an international observational studyShilpanjali Jesudason, Erandi Hewawasam, Brona Moloney, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2025
Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra LeoneKaty Kuhrt, Rossetta Cole, Moses M'Bayoh, et al.
Journal of Nephrology|January 18, 2023
Prevalence of chronic kidney disease in women of reproductive age and observed birth ratesWillemijn A L Vrijlandt, Margriet F C de Jong, Jelmer R Prins, et al.
Obstetrics and Gynecology|August 25, 2010
The active implementation of pregnancy hypertension guidelines in British ColumbiaPeter von Dadelszen, Diane Sawchuck, Romy McMaster, et al.
Reproductive Health|October 11, 2016
Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative studyTabassum Firoz, Marianne Vidler, Prestige Tatenda Makanga, et al.
Lancet (London, England)|December 7, 2025
Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trialJames Goadsby, Argyro Syngelaki, Laura A Magee, et al.
Pageof 45